FASANO, Serena
 Distribuzione geografica
Continente #
NA - Nord America 657
EU - Europa 622
AS - Asia 452
SA - Sud America 38
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.771
Nazione #
US - Stati Uniti d'America 650
IE - Irlanda 313
HK - Hong Kong 245
SG - Singapore 89
IT - Italia 82
GB - Regno Unito 69
CN - Cina 55
DE - Germania 32
BR - Brasile 31
GR - Grecia 27
FR - Francia 26
SE - Svezia 25
UA - Ucraina 22
KR - Corea 20
JP - Giappone 11
TR - Turchia 11
IN - India 8
FI - Finlandia 6
RU - Federazione Russa 5
PT - Portogallo 4
AR - Argentina 3
MY - Malesia 3
AT - Austria 2
BD - Bangladesh 2
BE - Belgio 2
CL - Cile 2
CZ - Repubblica Ceca 2
PA - Panama 2
PL - Polonia 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
CA - Canada 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
ES - Italia 1
EU - Europa 1
GL - Groenlandia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MX - Messico 1
RO - Romania 1
UZ - Uzbekistan 1
VN - Vietnam 1
Totale 1.771
Città #
Dublin 313
Hong Kong 244
Santa Clara 177
Chandler 96
Jacksonville 69
Princeton 33
Roxbury 32
Singapore 25
Medford 24
Bremen 20
Seoul 20
Caserta 15
Cambridge 11
Des Moines 11
Nanjing 8
Wilmington 8
Beijing 7
Boardman 7
Jinan 7
Tokyo 7
Ann Arbor 6
The Dalles 6
Marseille 5
Naples 5
Napoli 4
New York 4
Sant'Angelo in Formis 4
Villa Literno 4
Falkenstein 3
Hyderabad 3
Milan 3
Shenyang 3
Ashburn 2
Brussels 2
Campo Grande 2
Changsha 2
Guangzhou 2
Hebei 2
Jiaxing 2
Kraków 2
Kuala Lumpur 2
Lanzhou 2
Lappeenranta 2
Lisbon 2
Los Angeles 2
Lucknow 2
Mcallen 2
Minerbio 2
Mountain View 2
Nanchang 2
Redwood City 2
Rio de Janeiro 2
San Mateo 2
Santiago 2
Taiyuan 2
Taizhou 2
Tianjin 2
Villaricca 2
Zhengzhou 2
Almaty 1
Amman 1
Araraquara 1
Arroio Grande 1
Athens 1
Baku 1
Bishkek 1
Brasília 1
Brno 1
Brookline 1
Bucharest 1
Buenos Aires 1
Cagliari 1
Chapecó 1
Colombo 1
Contagem 1
Coronel Fabriciano 1
Council Bluffs 1
Davis 1
Dhaka 1
Edinburgh 1
Estância 1
Ferrara 1
Garanhuns 1
Genova 1
Guarapuava 1
Guareí 1
Guarulhos 1
Guayaquil 1
Gunzenhausen 1
Haikou 1
Harbin 1
Helsinki 1
Hongtong 1
Hortolândia 1
Jarinu 1
Jaú 1
Jequié 1
Kiev 1
Kunming 1
Manaus 1
Totale 1.279
Nome #
Biologic treatments for idiopathic inflammatory myopathies 122
Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus 66
Low-dose aspirin as primary prophylaxis for cardiovascular events in systemic lupus erythematosus: A long-term retrospective cohort study 65
Prevalence and factors associated with glucocorticoids (GC) use in systemic sclerosis (SSc): a systematic review and meta-analysis of cohort studies and registries 61
Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis (otherwise referred to as very early-early systemic sclerosis): a TDI study 58
The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts: Implication of disease-associated and traditional risk factors as emerged by a 16-year retrospective GIRRCS study 58
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 56
Mortality in Italian patients with rheumatoid arthritis: Evidence for a low mortality rate from cancer and infections in patients followed up at a tertiary center 55
Low-dose aspirin as primary prophylaxis for cardiovascular events in rheumatoid arthritis: an Italian multicentre retrospective study 55
Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: Putative implication of a low anti-carbamylated protein antibodies prevalence 54
Clinical features of patients with systemic lupus erythematosus according to health-related quality of life, entity of pain, fatigue and depression: a cluster analysis 51
Current pharmacological treatment of idiopathic inflammatory myopathies 50
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 50
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 49
Rituximab in the treatment of inflammatory myopathies: a review 47
Lung involvement in stable undifferentiated connective tissue diseases: a rheumatology perspective 47
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease. 45
Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review 42
Undifferentiated connective tissue disease at risk of systemic sclerosis: A weighted score to identify patients who will evolve 42
ILC3 in Axial Spondyloarthritis: the Gut Angle 41
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 39
Precision medicine in systemic lupus erythematosus 39
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 39
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 35
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study 34
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual 33
Subclinical Pancreatitis as Onset of Systemic Lupus Erythematosus: Case Report and Review of the Literature 33
"What is fuelling the immune response in systemic lupus erythematosus?" Evaluating the key metabolites driving plasmablast differentiation 32
Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE? 32
The association between duration of remission, fatigue, depression and health-related quality of life in Italian patients with systemic lupus erythematosus 32
Thrombocytopenia in the Antiphospholipid Syndrome 31
Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation 30
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus 30
Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review 29
Vasodilators and low-dose acetylsalicylic acid are associated with a lower incidence of distinct primary myocardial disease manifestations in systemic sclerosis: Results of the DeSScipher inception cohort study 29
Present and novel biologic drugs in primary Sjogren's syndrome 27
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study 24
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus 23
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 22
The role of aspirin in the primary prevention of accelerated atherosclerosis in systemic autoimmune rheumatic diseases 22
Risk factors of flare in patients with systemic lupus erythematosus after glucocorticoids withdrawal. A systematic review and meta-analysis 22
Systemic lupus erythematosus and the role of the GP 21
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 19
Recognition and management of systemic lupus erythematosus 18
Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview 17
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus 14
Totale 1.840
Categoria #
all - tutte 10.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.157


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202011 0 0 0 0 0 0 0 0 0 4 6 1
2020/2021132 2 0 5 7 37 8 24 2 8 3 35 1
2021/2022193 5 0 0 3 82 0 9 4 10 3 12 65
2022/2023485 39 3 20 14 50 29 0 23 281 1 13 12
2023/2024191 16 17 13 15 80 6 0 1 1 1 5 36
2024/2025631 1 20 4 13 99 94 91 106 63 140 0 0
Totale 1.840